DI CATALDO, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 1.062
EU - Europa 836
AS - Asia 271
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 2.176
Nazione #
US - Stati Uniti d'America 1.060
RU - Federazione Russa 467
IT - Italia 117
IE - Irlanda 96
HK - Hong Kong 86
SG - Singapore 75
PL - Polonia 58
CN - Cina 52
SE - Svezia 50
JO - Giordania 30
DE - Germania 15
FI - Finlandia 15
KR - Corea 11
IN - India 10
GB - Regno Unito 6
CI - Costa d'Avorio 5
CA - Canada 2
CZ - Repubblica Ceca 2
ES - Italia 2
FR - Francia 2
GR - Grecia 2
PH - Filippine 2
UA - Ucraina 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
JP - Giappone 1
LK - Sri Lanka 1
LT - Lituania 1
TR - Turchia 1
Totale 2.176
Città #
Santa Clara 320
Chandler 120
Dublin 96
Ashburn 68
Fairfield 65
Hong Kong 62
Warsaw 58
Singapore 56
Seattle 36
Houston 33
Woodbridge 31
Cambridge 30
Florence 24
Wilmington 24
Lawrence 19
Altamura 18
New York 18
Dearborn 16
Beijing 15
Shanghai 15
Princeton 14
Boston 11
Kent 11
Munich 11
Seoul 11
West Jordan 11
Buffalo 10
Moscow 9
Ann Arbor 8
Helsinki 8
Los Angeles 7
Rome 7
San Diego 7
Mumbai 6
Abidjan 5
Guangzhou 5
Medford 5
Boardman 4
Bologna 4
Milan 4
Fontebuona 3
Norwalk 3
Pontedera 3
Pune 3
Shenzhen 3
Yubileyny 3
Barcelona 2
Bergamo 2
Bojano 2
Brescia 2
Castelliri 2
Dong Ket 2
Empoli 2
Garden City 2
Hillsboro 2
Paris 2
Scarperia e San Piero 2
Southwark 2
Thessaloniki 2
Toronto 2
Washington 2
Andover 1
Arezzo 1
Bari 1
Cabanatuan City 1
Chiari 1
Colle di Val d'Elsa 1
Colombo 1
Frankfurt am Main 1
Genoa 1
Gorgonzola 1
Hebei 1
Hefei 1
Lappeenranta 1
London 1
Lucca 1
Mcallen 1
Padova 1
Phoenix 1
Ponte Buggianese 1
Prague 1
Quezon City 1
Quzhou 1
Redmond 1
Redwood City 1
Romola 1
Rui'an 1
Sassari 1
Sydney 1
São Paulo 1
Vicopisano 1
Vienna 1
Totale 1.361
Nome #
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 187
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 126
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 119
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 117
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 113
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 109
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 94
Nutritional Supplement Based on Zinc, Prebiotics, Probiotics and Vitamins to Prevent Radiation-related Gastrointestinal Disorders 92
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 75
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 70
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 66
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 64
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 63
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 63
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 62
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 62
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 60
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 59
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 58
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 58
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 55
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 55
Update chemotherapy schedule in the treatment of lung cancer 53
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 48
Synchronous bilateral testicular germ cell tumour: Case report and review of the literature 46
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 45
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 44
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 43
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 38
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 38
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 22
Totale 2.204
Categoria #
all - tutte 9.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 0 25 28 23 24 17 14 15 6
2020/202188 6 9 5 13 3 7 13 6 7 10 5 4
2021/202289 0 10 2 13 3 1 1 11 3 3 14 28
2022/2023443 22 70 13 22 48 88 62 40 61 2 14 1
2023/2024304 14 18 33 19 16 54 17 76 0 19 26 12
2024/2025996 37 156 99 292 412 0 0 0 0 0 0 0
Totale 2.204